Professional Profile
Dr. Ling Liu is Managing Scientist in ToxStrategies’ Pharmaceuticals/Biopharmaceuticals Practice. She is a board-certified toxicologist with 20 years of toxicology and drug discovery experience in the pharmaceutical industry, with both large pharmaceutical companies and small start-ups. She has nonclinical experience with biologic, small-molecule products, and gene therapy in a wide variety of therapeutic indications, including neurology, muscular dystrophy, oncology, metabolic disease, and rare diseases, as well as multiple routes of administration (oral, intravenous, subcutaneous, intracerebroventricular).
She has experience as a project-team liaison on multidisciplinary discovery and development project teams, responsible for developing and implementing the nonclinical safety strategy to support nonclinical development of pipeline assets, and writing regulatory submissions (pre-INDs, INDs, IBs, briefing books) and due diligence evaluations.
Dr. Liu also specializes in directing and monitoring both non-GLP and GLP toxicity studies, as well as more complex gene therapy studies. She has expertise in protocol development, design, conduct, data interpretation, and reporting of nonclinical toxicity studies in mice, rats, rabbits, dogs, and nonhuman primates. With a background in developmental biology and pharmacology, Dr. Liu understands target pathways, underlying biological mechanisms of disease states, and the biological mechanisms of toxicity.
Prior to joining ToxStrategies, Dr. Liu worked as a toxicologist in the pharmaceutical industry and as a pharmacologist for a start-up company.